Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.434 USD | +0.93% | -18.55% | -93.68% |
Apr. 16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock Market
- Equities
- GRI Stock
- News GRI BIOPAR
- Vallon Pharmaceuticals' Stockholders Approve Merger With GRI Bio, Reverse Stock Split